Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors
Open accessThe DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Abstract
Interfering with Ets transcription factor function reverses multiple aspects of the transformed phenotype of mouse or human tumor cells. However, the unknown number of individual Ets factors expressed in any cellular context and the similar DNA binding specificities of Ets family members complicates the identification of those that mediate transformation. By utilizing quantitative PCR assays for 25 mouse Ets factors, we analyzed the expression of essentially the entire Ets family in normal mammary tissue, mammary-related cell lines, and mammary tumors. In normal mammary tissue, 24 Ets factors were expressed. Even clonal derived cell lines expressed 14-20 Ets members. The most abundant Ets factor mRNAs measured in normal mammary tissue were Elk4, Elf1, and Ets2. Subtractive analysis of mammary tissue identified which Ets factors were predominantly expressed in the myeloid/lymphoid or epithelial cell compartments. Comparison of Ets factor expression in normal mammary tissue and mammary tumors identified significantly elevated expression of Pse/PDEF, Ese2/Elf5, Ese3/Ehf, TEL/Etv6, and Elf2/NERF in mammary tumors and confirmed previously reported alterations in expression of Ese1/Elf3 and the PEA3 subfamily. Expression of 13 Ets target genes, implicated in various aspects of tumor progression, was also analyzed. Altered expression of particular Ets target genes was significantly correlated with particular Ets factors (e.g. maspin and Ese2), suggesting specific in vivo regulatory roles. Together, this comprehensive analysis revealed unexpectedly diverse Ets family gene expression, characterized novel Ets factor changes in mammary tumors, and implicated specific Ets factors in the regulation of multiple genes involved in mammary tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In any particular cell type, 14 to 25 family members are coexpressed.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Half of the family members are ubiquitously expressed in all cell types tested.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“In spite of the biological and biochemical evidence that different ETS proteins can execute diverse roles, an extensive overlap in the expression of various family members is found in many human tissues.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
In the citing paper
“Expression profiles in transformed cell lines show strong similarity to those in matching normal tissues, although exceptions are worth noting.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Self-citationGuy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Self-citationThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Ball, R. K., Friis, R. R., Schoenenberger, C. A., Doppler, W., & Groner, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03048.x · Cited by 504
Zhong, H., & Simons, J. W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0815 · Cited by 470
Research works printed but not linked: 15
- 5. Dittmer, J. ∙ Nordheim, A. Biochim. Biophys. Acta. 1998; 1377:F1-F11 PubMed Google Scholar
- 8. Langer, S.J. ∙ Bortner, D.M. ∙ Roussel, M.F. ... Mol. Cell. Biol. 1992; 12:5355-5362 Crossref Scopus (147) PubMed Google Scholar
- 11. de Nigris, F. ∙ Mega, T. ∙ Berger, N. ... Cancer Res. 2001; 61:2267-2275 PubMed Google Scholar
- 12. Sapi, E. ∙ Flick, M.B. ∙ Rodov, S. ... Cancer Res. 1998; 58:1027-1033 PubMed Google Scholar
- 17. Neznanov, N. ∙ Man, A.K. ∙ Yamamoto, H. ... Cancer Res. 1999; 59:4242-4246 PubMed Google Scholar
- 18. Trimble, M.S. ∙ Xin, J.H. ∙ Guy, C.T. ... Oncogene. 1993; 8:3037-3042 PubMed Google Scholar
- 22. Andrechek, E.R. ∙ Laing, M.A. ∙ Girgis-Gabardo, A.A. ... Cancer Res. 2003; 63:4920-4926 PubMed Google Scholar
- 24. Ghadersohi, A. ∙ Sood, A.K. Clin. Cancer Res. 2001; 7:2731-2738 PubMed Google Scholar
- 27. Boyd, K.E. ∙ Farnham, P.J. Proc. Soc. Exp. Biol. Med. 1999; 222:9-28 Crossref Scopus (36) PubMed Google Scholar
- 36. Guy, C.T. ∙ Cardiff, R.D. ∙ Muller, W.J. Mol. Cell. Biol. 1992; 12:954-961 Crossref Scopus (1346) PubMed Google Scholar
- 41. Rozen, S. ∙ Skaletsky, H.J. Krawetz, S. ∙ Misener, S. (Editors) Bioinformatics Methods and Protocols: Methods in Molecular Biology Humana Press, Totowa, NJ, 2000; 365-386 Google Scholar
- 56. Chen, J.H. ∙ Vercamer, C. ∙ Li, Z. ... Oncogene. 1996; 13:1667-1675 PubMed Google Scholar
- 57. Zhang, M. ∙ Maass, N. ∙ Magit, D. ... Cell Growth Differ. 1997; 8:179-186 PubMed Google Scholar
- 64. Feldman, R.J. ∙ Sementchenko, V.I. ∙ Gayed, M. ... Cancer Res. 2003; 63:4626-4631 PubMed Google Scholar
- 70. Nozawa, M. ∙ Yomogida, K. ∙ Kanno, N. ... Cancer Res. 2000; 60:1348-1352 PubMed Google Scholar
Cited by
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
“Oncogene Interestingly, both the microarray and PCR data showed that silencing of vimentin resulted in upregulation of several genes (RAB25, EHF and KLK5, kallikrein 5) (Figure 3b) that are highly expressed in normal mammary epithelium (Galang et al., 2004; Cheng et al., 2006).”
BackgroundSIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., et al. (2012) · Nature · doi:10.1038/nature11043 · Cited by 620
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
“Despite similar specificities and overlapping expression patterns (Galang et al, 2004; Hollenhorst et al, 2004; Richardson et al, 2010; Supplementary Figure S7), loss-of-function studies have re- vealed that ETS-family TFs have very specific functions during development (Bartel et al, 2000).”
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“There is high expression of SPDEF and ESE subfamily members in mammary tumors (35), and a striking prevalence of ETV4 expression in cell lines versus normal matching adult tissues (34).”
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
Significance, detection and markers of disseminated breast cancer cells
Lacroix, M. (2006) · Endocrine-Related Cancer · doi:10.1677/erc-06-0001 · Cited by 293
“1043 Downloaded from Bioscientifica.com at 12/27/2018 05:40:20PM via free access In a micro-array approach, Backus et al. (2005) analysed RNA from samples covering normal, benign and cancerous tissues from breast, colon, lung, ovarian, prostate and peripheral blood leukocytes from healthy donors.”
MethodHollenhorst, P. C., Shah, A. A., Hopkins, C., & Graves, B. J. (2007) · Genes & Development · doi:10.1101/gad.1561707 · Cited by 290
“Interestingly, this predicted specificity must exist in an environment in which multiple ETS proteins are present, because more than half of the 27 human ETS genes are expressed in any particular cell type (Galang et al. 2004; Hollenhorst et al. 2004).”
BackgroundCauses and consequences of DNA hypomethylation in human cancer
Hoffmann, M. J., & Schulz, W. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-036 · Cited by 252
ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Oh, S., Shin, S., & Janknecht, R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.002 · Cited by 249
“A comprehensive screen of ETS genes in HER2/Neu-induced mouse mammary tumors indicated that not only the PEA3 group becomes upregulated, but also other ETS genes, albeit the PEA3 group shows the highest difference in mRNA molecules per cell between normal and tumor tissue; in addition, most of the ETS genes are expres…”
BackgroundDNA Specificity Determinants Associate with Distinct Transcription Factor Functions
Hollenhorst, P. C., Chandler, K. J., Poulsen, R. L., Johnson, W. E., Speck, N. A., & Graves, B. J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000778 · Cited by 198
“ETS family members are extensively coexpressed [8,9].”
Hollenhorst, P. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh906 · Cited by 214
“Our findings extend a more focused study on mouse mammary cells that detected mRNA for 24 ets genes in normal tissue and for 14–20 genes in cell lines (4).”
Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning
Donnison, M., Beaton, A., Davey, H. W., Broadhurst, R., L'Huillier, P., & Pfeffer, P. L. (2005) · Development · doi:10.1242/dev.01819 · Cited by 213
“Presently no in vivo role for Elf5 has been demonstrated though Elf5 expression appears to be increased significantly in mouse mammary tumors relative to in normal mammary tissue (Galang et al., 2004).”
BackgroundLessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Fluck, M. M., & Schaffhausen, B. S. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00009-09 · Cited by 179
The role of sirtuins in aging and age-related diseases
Wątroba, M., & Szukiewicz, D. (2016) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.09.003 · Cited by 173
Socs2 and Elf5 Mediate Prolactin-Induced Mammary Gland Development
Harris, J., Stanford, P. M., Sutherland, K. D., Oakes, S. R., Naylor, M. J., Robertson, F. G., Blazek, K. D., Kazlauskas, M., Hilton, H. N., Wittlin, S., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0473 · Cited by 156
Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens
Cheng, J., DeCaprio, J. A., Fluck, M. M., & Schaffhausen, B. S. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.03.002 · Cited by 160
Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
Xu, D., Dwyer, J., Li, H., Duan, W., & Liu, J.-P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800790200 · Cited by 142
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 169
“…of 27 ETS genes in humans, 26 in mice, 10 in Caenorhabditis elegans, and 9 in Drosophila, which can be structurally categorized into 11 subfamilies (ETS, ERG, ELG, ELF, ESE, ERF, TEL, PEA3, SPI, TCF and PDEF; Figure 1; Galang et al., 2004; Gutierrez-Hartmann et al., 2007; Hollenhorst et al., 2004).”
BackgroundETS transcription factors in endocrine systems
Gutierrez‐Hartmann, A., Duval, D. L., & Bradford, A. P. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.03.002 · Cited by 148
Lee, C. M., Fuhrman, C. B., Planelles, V., Peltier, M. R., Gaffney, D. K., Soisson, A. P., Dodson, M. K., Tolley, H. D., Green, C. L., & Zempolich, K. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1084 · Cited by 135
Cea, M., Cagnetta, A., Adamia, S., Acharya, C., Tai, Y.-T., Fulciniti, M., Ohguchi, H., Munshi, A., Acharya, P., Bhasin, M. K., et al. (2016) · Blood · doi:10.1182/blood-2015-06-649970 · Cited by 121
The Ets transcription factors of the PEA3 group: Transcriptional regulators in metastasis
de Launoit, Y., Baert, J., Chotteau‐Lelièvre, A., Monté, D., Coutte, L., Mauën, S., Firlej, V., Degerny, C., & Verreman, K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.002 · Cited by 129
Molecular Profiling of Heart Endothelial Cells
Zhang, L., Hoffman, J. A., & Ruoslahti, E. I. (2005) · Circulation · doi:10.1161/circulationaha.104.529537 · Cited by 107
Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
An integrated ChIP-seq analysis platform with customizable workflows
Giannopoulou, E. G., & Elemento, O. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-277 · Cited by 92
“In the supervised analysis on the promoter peaks ChIPseeqerMotifMatch module), we determined subsets of ETS1 peaks that contain motif occurrences for other ETS family members (e.g., SPI1, SPIB, ELK1) [43,47,48], using motif weight matrices from the JASPAR [49] and UniPROBE [50] databases.”
MethodNovel Role for PDEF in Epithelial Cell Migration and Invasion
Gunawardane, R. N., Sgroi, D. C., Wrobel, C. N., Koh, E. Y., Daley, G. Q., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1196 · Cited by 96
“Furthermore, murine PDEF (mPSE) was found to be significantly elevated in mammary tumors in both PyMT and ErbB2 tumor models (5).”
Hu, Y., Sun, H., Drake, J. A., Kittrell, F. S., Abba, M. C., Deng, L., Gaddis, S., Şahin, A. A., Baggerly, K., Medina, D., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1827 · Cited by 86
“This observation is in agreement with a very recent report that analyzed expression of various Ets transcription factors in mammary tissues (28).”
ResultHeo, S., Choi, Y., Ryoo, H., & Cho, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22175 · Cited by 95
“Elk4, Elf-1, and Ets-2 are the most abundant Ets factors in normal mammary tissue, while Pdef, ESE-2, ESE-3, Tel, and Elf-2 are at higher expression levels in mammary tumors compared to normal mammary tissue (Galang et al., 2004).”
BackgroundPellecchia, A., Pescucci, C., Lorenzo, E. D., Luceri, C., Passaro, N., Sica, M., Notaro, R., & Angioletti, M. D. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.20 · Cited by 85
McBryan, J., Howlin, J., Kenny, P. A., Shioda, T., & Martin, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210468 · Cited by 80
“Reports have shown high levels of ehf and tnfrsf12a in breast tumours (Galang et al., 2004; Michaelson et al., 2005).”
BackgroundEts2 is required for trophoblast stem cell self-renewal
Wen, F., Tynan, J. A., Ceceña, G., Williams, R. M., Múnera, J. O., Mavrothalassitis, G., & Oshima, R. G. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.09.024 · Cited by 73
“RNA isolation from TS cells, cDNA preparation and real-time PCR were performed as described previously (Galang et al., 2004).”
BackgroundMethodSelf-citationMunde, M., Wang, S., Kumar, A., Stephens, C. E., Farahat, A. A., Boykin, D. W., Wilson, W. D., & Poon, G. M. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt955 · Cited by 68
Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia
Kornblau, S. M., Qiu, Y. H., Zhang, N., Singh, N., Faderl, S. H., Ferrajoli, A., York, H., Qutub, A. A., Coombes, K. R., & Watson, D. K. (2011) · Blood · doi:10.1182/blood-2011-04-348052 · Cited by 76
Buchwalter, G., Hickey, M. M., Cromer, A., Selfors, L. M., Gunawardane, R. N., Frishman, J., Jeselsohn, R. M., Lim, E., Chi, D., Fu, X., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.026 · Cited by 72
“, 2005) and is one of the most highly overexpressed genes in human and mouse mammary tumors and in lymph node metastases (Galang et al., 2004; Ghadersohi and Sood, 2001).”
Sood, A. K., Saxena, R., Groth, J., Desouki, M. M., Cheewakriangkrai, C., Rodabaugh, K. J., Kasyapa, C. S., & Geradts, J. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.03.010 · Cited by 65
“The latter potential stems from (i) the high degree of sequence homology approaching 45% to 55% amino acid sequence identity in the DNA binding domain between PDEF and other Ets factors [11], and (ii) the large number of Ets factors that are expressed in normal mammary gland, and several at much higher levels than pro…”
BackgroundETS-dependent regulation of a distal Gata4 cardiac enhancer
Schachterle, W., Rojas, A., Xu, S.-M., & Black, B. L. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.023 · Cited by 64
“Analysis of relative gene expression was performed as previously described (Galang et al., 2004).”
MethodRcl is a novel ETV1/ER81 target gene upregulated in breast tumors
Shin, S., Bosc, D. G., Ingle, J. N., Spelsberg, T. C., & Janknecht, R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21884 · Cited by 63
“Moreover, ETV1 mRNA levels are increased in murine cell lines and tumors overexpressing HER2/Neu [Shepherd et al., 2001; Galang et al., 2004] and also in many human breast cancer cell lines [Baert et al.”
BackgroundScheiber, M. N., Watson, P. M., Rumboldt, T., Stanley, C., Wilson, R. C., Findlay, V. J., Anderson, P. E., & Watson, D. K. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.007 · Cited by 65
“Earlier studies in mice found reduced FLI1 mRNA and cDNA in mammary tumors compared to normal tissue and cell lines [44] and in human breast cancer cell lines and tumor tissue compared to immortalized human breast epithelial cell lines [45].”
BackgroundMetzger, D. E., Xu, Y. J., & Shannon, J. M. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21133 · Cited by 53
“Supporting this concept, a previous study has shown that Elf5 is increased in mouse mammary tumor models (Galang et al., 2004).”
MethodDefining ETS transcription regulatory networks and their contribution to breast cancer progression
Turner, D. P., Findlay, V. J., Moussa, O., & Watson, D. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21494 · Cited by 55
“Studies examining ETS factor expression profiles in normal and cancerous breast cells have demonstrated that a diverse combination of at least 25 of 27 ETS family members examined are expressed at any one time in these cells [Galang et al., 2004; Hollenhorst et al., 2004].”
BackgroundCostello, P. S., Nicolas, R. H., Willoughby, J. E., Wasylyk, B., Nordheim, A., & Treisman, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000472 · Cited by 53
ETS-4 Is a Transcriptional Regulator of Life Span in Caenorhabditis elegans
Thyagarajan, B., Blaszczak, A. G., Chandler, K. J., Watts, J. L., Johnson, W. E., & Graves, B. J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001125 · Cited by 51
“However, discerning molecular mechanisms of ETS protein function in mice has been complicated by the large number of ETS paralogs expressed in any particular cell type [15,16].”
BackgroundMesquita, B., Lopes, P., Rodrigues, A., Pereira, D., Afonso, M. G., Leal, C., Henrique, R., Lind, G. E., Jerónimo, C., Lothe, R. A., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2408-2 · Cited by 59
“evaluated in primary breast carcinomas [32, 33].”
Wang, S., Poon, G. M. K., & Wilson, W. D. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2877-4_20 · Cited by 52
Regulatory mechanisms of Robo4 and their effects on angiogenesis
Dai, C., Gong, Q., Cheng, Y., & Su, G. (2019) · Bioscience Reports · doi:10.1042/bsr20190513 · Cited by 59
Ghadersohi, A., Pan, D., Fayazi, Z. S., Hicks, D. G., Winston, J. S., & Li, F. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9314-9 · Cited by 50
Firlej, V., Ladam, F., Brysbaert, G., Dumont, P., Fuks, F., de Launoit, Y., Benecke, A., & Chotteau‐Lelièvre, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.027201 · Cited by 51
“, 2007) or cyclin D1 (a gene implicated in G1-S transition) for which a correlation has been established with pea3 expression in different mammary tissues and tumors (Galang et al., 2004).”
BackgroundRamnath, D., Irvine, K. M., Lukowski, S. W., Horsfall, L. U., Loh, Z., Clouston, A. D., Patel, P. J., Fagan, K. J., Iyer, A., Lampe, G., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120274 · Cited by 47
“01 Fibrosis stageA 0 6 (23) NA NA 3 (10) NA NA 3 (22) NA NA 1 5 (19) NA 5 (17) NA 5 (36) NA 2 5 (19) NA 8 (28) NA 2 (14) NA 3 NA 7 (27) NA 5 (17) NA 2 (14) 4 NA 3 (12) NA 8 (28) NA 2 (14) AData presented categorically as n (%) and analyzed using χ2 test.”
Ets transcription factors in intestinal morphogenesis, homeostasis and disease.
Jedlicka, P., & Gutierrez‐Hartmann, A. (2008) · PubMed · doi:10.14670/hh-23.1417 · Cited by 45
ELF5 isoform expression is tissue-specific and significantly altered in cancer
Piggin, C., Roden, D. L., Gallego‐Ortega, D., Lee, H. J., Oakes, S. R., & Ormandy, C. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0666-0 · Cited by 50
“The ETS family as a whole has previously been studied in breast cancer at the qPCR level in mouse models [70] and human cell lines [71], although the present study is the first, to our knowledge, to include examination of the expression of the entire human ETS family in both the normal breast and subtyped breast cance…”
MethodThe promise and challenge toward the clinical application of maspin in cancer
Sheng, S. (2004) · Frontiers in bioscience · doi:10.2741/1432 · Cited by 44
“Indeed, three recent studies identified maspin as a target of prostatederived Ets factor (PDEF) in normal breast epithelial cells as well as in breast cancer cells (87-89).”
Nath, A. K., Krauthammer, M. O., Li, P., Davidov, E., Butler, L. C., Copel, J. A., Katajamaa, M., Orešič, M., Buhimschi, I. A., Buhimschi, C. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004221 · Cited by 41
“Several candidate factors in our dataset have been correlated with disease states including the Ets family member Elf5, which is upregulated in breast cancer [43].”
BackgroundZhu, X. M., Zhang, J., Fan, W., Wang, F., Yao, H., Wang, Z., Hou, S., Tian, Y., Fu, W., Xie, D., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt061 · Cited by 40
Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter
Haro, L. D., & Janknecht, R. (2005) · Genomics · doi:10.1016/j.ygeno.2004.12.003 · Cited by 42
Schaefer, J. S., Sabherwal, Y., Shi, H. Y., Sriraman, V., Richards, J. S., Minella, A. C., Turner, D. P., Watson, D. K., & Zhang, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073932 · Cited by 38
Lee, H. J., & Ormandy, C. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.02.006 · Cited by 41
Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells
Shinoda, Y., Kozaki, K., Imoto, I., Obara, W., Tsuda, H., Mizutani, Y., Shuin, T., Fujioka, T., Miki, T., & Inazawa, J. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00495.x · Cited by 37
Ets2 transcription factor in normal and neoplastic human breast tissue
Buggy, Y., Maguire, T. M., McDermott, E. W. M., Hill, A. D. K., O’Higgins, N. J., & Duffy, M. J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.018 · Cited by 40
The role of the transcription factor ETV5 in insulin exocytosis
Gutiérrez‐Aguilar, R., Kim, D. H., Casimir, M., Dai, X., Pfluger, P. T., Park, J., Haller, A. M., Donelan, E. M., Park, J., D’Alessio, D. D., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3096-5 · Cited by 37
“ETS factors are ubiquitously expressed in developing and adult mammalian tissues [2].”
Braunschweig, M. H., & Leeb, T. (2006) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(06)72488-2 · Cited by 35
“However, there is evidence that other E26 domain factors are involved in gene regulation in the mammary gland ( Galang et al., 2004 ).”
BackgroundETV6 gene rearrangements in invasive breast carcinoma
Letessier, A., Ginestier, C., Charafe‐Jauffret, E., Cervera, N., Adélaı̈de, J., Gelsi‐Boyer, V., Ahomadegbe, J., Bénard, J., Jacquemier, J. D., Birnbaum, D., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20200 · Cited by 35
“Expression of several ETS factors, including ETV6, is modulated in mammary tumors (Edel 1999; Galang et al., 2004).”
BackgroundBrenne, K., Nymoen, D. A., Falkenthal, T. E. H., Tropé, C. G., & Davidson, B. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.05.023 · Cited by 32
“Elevated expression levels of EHF mRNA have previously been detected in breast and colorectal carcinoma [21-23], whereas decreased expression of EHF mRNA has been observed in prostate and head and neck carcinoma [24,25].”
BackgroundCosi, I., Pellecchia, A., Lorenzo, E. D., Torre, E., Sica, M., Nesi, G., Notaro, R., & Angioletti, M. D. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00943-w · Cited by 35
The function of the ELF3 gene and its mechanism in cancers
Ju, Y., Fang, S., Liu, L., Ma, H., & Zheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122637 · Cited by 34
Sam-Pointed Domain Containing Ets Transcription Factor in Luminal Breast Cancer Pathogenesis
Sood, A. K., Wang, J., Mhawech-Fauceglia, P. Y., Jana, B., Liang, P., & Geradts, J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0055 · Cited by 35
“Additionally, high SPDEF expression was reported in mammary tumors arising in the two transgenic mouse lines including the rat neu and the polyoma virus-middle T antigen transgenic lines (25).”
BackgroundPerkins, T. N., Peeters, P. M., Shukla, A., Arijs, I., Dragon, J. A., Wouters, E. F. �., Reynaert, N. L., & Mossman, B. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu551 · Cited by 33
“increased significantly in mouse mammary tumors relative to normal tissue (66).”
BackgroundControl of mammary tumor differentiation by SKI-606 (bosutinib)
Hebbard, L., Ceceña, G., Golas, J., Sawada, J., Ellies, L. G., Charbono, A., Williams, R. M., Jimenez, R. E., Wankell, M., Arndt, K. T., et al. (2010) · Oncogene · doi:10.1038/onc.2010.412 · Cited by 34
Self-citationCritical Requirement of GABPα for Normal T Cell Development
Yu, S., Zhao, D., Jothi, R., & Xue, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088740 · Cited by 31
Firlej, V., Bocquet, B., Desbiens, X., de Launoit, Y., & Chotteau‐Lelièvre, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408017200 · Cited by 32
Wegwitz, F., Kluth, M.-A., Maenz, C., Otto, B., Gruner, K., Heinlein, C., Kühl, M., Warnecke, G., Schumacher, U., Deppert, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012103 · Cited by 27
“As shown by qPCR analysis, expression of known regulators of normal and tumor mammary epithelial cell fate and function, namely Ehf [43], Elf5 [44], Etv5 [45], and Foxc1 [46] is stronger in the CD24ahigh subset (Figure 13B), whereas the CD24alow subset is distinguished by a higher expression of the Twist2 gene (Figure…”
BackgroundInfluentialFunctional dissection of breast cancer risk-associated TERT promoter variants
Helbig, S., Wockner, L. F., Bouendeu, A., Hille‐Betz, U., McCue, K., French, J. D., Edwards, S. L., Pickett, H. A., Reddel, R. R., Chenevix‐Trench, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18226 · Cited by 30
“It has been proposed that ETS2, a member of the ETS transcription factor family which is highly abundant in mammary tissues [64], cooperates with MYC in the regulation of TERT promoter activity in breast cancer cells [28].”
BackgroundAppel, S., Bringmann, A., Grünebach, F., Weck, M. M., Bauer, J. M., & Brossart, P. (2005) · Blood · doi:10.1182/blood-2005-06-2480 · Cited by 28
“reported elevated expression of ESE-3 in mammary tumors.(24) Using RT-PCR and Western blot analyses, we found that ESE-3 expression is induced at an early stage during DC development from peripheral blood monocytes.”
MethodKerr, N. C. H., Pintzas, A., Holmes, F. E., Hobson, S., Pope, R. J. P., Wallace, M., Wasylyk, C., Wasylyk, B., & Wynick, D. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.03.005 · Cited by 24
“The novel isoforms could not have been detected in previous RT-PCR analyses, due to the relative positions of primers used (Galang et al., 2004; Giovane et al., 1997; Hollenhorst et al., 2004; Kobberup et al., 2007; Sahin et al., 2009), and are not conserved between different ELK factors except for…”
BackgroundLiebert, A., Jones, B. L., Danielsen, E. T., Olsen, A. K., Swallow, D. M., & Troelsen, J. T. (2016) · Annals of Human Genetics · doi:10.1111/ahg.12167 · Cited by 24
“…to regulate DNA binding or transcription and to play an important role in the differentiation, survival and proliferation of cells, including those of the intestine (Sharrocks, 2001; Galang et al., 2004; Hsu et al., 2004, Seth & Watson, 2005; Hollenhorst et al., 2011; Findlay et al., 2013).”
BackgroundWei, Y., Han, S., Wen, J., Liao, J., Liang, J., Yu, J., Chen, X., Xiang, S., Huang, Z., & Zhang, B. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00909-3 · Cited by 28
ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression
Watson, D. K., Turner, D. P., Scheiber, M. N., Findlay, V. J., & Watson, P. M. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010024 · Cited by 30
“Transcripts for 24 of 25 murine Ets factors are detected in normal mouse mammary tissue [113].”
BackgroundBaert, J.-L., Beaudoin, C., Monté, D., Degerny, C., Mauën, S., & de Launoit, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209801 · Cited by 24
“High levels of this messenger are detected in human (Baert et al., 1997) and mouse (Galang et al., 2004) metastatic mammary cancer cells.”
BackgroundGaroia, F., Grifoni, D., Trotta, V., Guerra, D., Pezzoli, C., & Cavicchi, S. (2004) · Mechanisms of Development · doi:10.1016/j.mod.2004.10.007 · Cited by 23
MicroRNA 17-92 Cluster Mediates ETS1 and ETS2-Dependent RAS-Oncogenic Transformation
Kabbout, M., Dakhlallah, D. A., Sharma, S. M., Bronisz, A., Srinivasan, R., Piper, M. G., Marsh, C. B., & Ostrowski, M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100693 · Cited by 25
“Previous work using dominant-negative approaches implicated ETS-family members as mediators of RAS transformation but were incapable of distinguishing which family members contributed to the transformed phenotype because multiple ETS family members with similar DNA binding properties are expressed in all cell lines an…”
BackgroundER81 Expression in Breast Cancers and Hyperplasia
Wang, Y.-Y., Wang, L., Chen, Y., Li, L., Yang, X.-T., Li, B., Song, S., Yang, L., Hao, Y., & Yang, J.-L. (2011) · Pathology Research International · doi:10.4061/2011/980513 · Cited by 22
“SAGE-Hindawi Access to Research Pathology Research International Volume 2011, Article ID 980513, 6 pages doi:10.4061/2011/980513”
InfluentialPea3 Transcription Factors and Wnt1-Induced Mouse Mammary Neoplasia
Baker, R., Kent, C. V., Silbermann, R. A., Hassell, J. A., Young, L. J. T., & Howe, L. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008854 · Cited by 25
“overexpression also occurs in human breast carcinomas”
Wang, L., Xing, J., Cheng, R., Shao, Y., Li, P., Zhu, S., & Zhang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126319 · Cited by 21
Role of Ets Proteins in Development, Differentiation, and Function of T‐Cell Subsets
Liu, M., Gao, W., van Velkinburgh, J. C., Wu, Y., Ni, B., & Tian, Y. (2015) · Medicinal Research Reviews · doi:10.1002/med.21361 · Cited by 24
E74-like factor 2 regulates valosin-containing protein expression
Zhang, B., Tomita, Y., Qiu, Y., He, J., Morii, E., Noguchi, S., & Aozasa, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.160 · Cited by 21
Kar, A., & Gutierrez‐Hartmann, A. (2017) · Oncotarget · doi:10.18632/oncotarget.18710 · Cited by 19
Walker, D. M., Poczobutt, J. M., Gonzales, M. S., Horita, H. N., & Gutierrez‐Hartmann, A. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010077 · Cited by 18
“1874-0790/10 2010 Bentham Open Keywords: ETS, transformation, breast cancer, shRNA.”
Kathuria, H., Cao, Y. X., Hinds, A., Ramirez, M. I., & Williams, M. C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21270 · Cited by 18
“Identifying the ETS transcription factors responsible for transactivating the caveolin-1 promoter is complex because they comprise a very large family of proteins of more than 25 members in both mice and humans [Sharrocks, 2001; Galang et al., 2004; Hollenhorst et al., 2004].”
BackgroundInfluentialAlonso, M. E., Bello, M. J., Arjona, D., Martínez‐Glez, V., de Campos, J. M., Isla, A., Kusak, M. E., Vaquero, J., Gutiérrez, M., Sarasa, J. L., et al. (2005) · American Journal of Clinical Pathology · doi:10.1309/448yrwnc43te32kq · Cited by 17
Escamilla, R., Chakrabarti, R., Romano, R.-A., Smalley, K., Zhu, Q., Lai, W., Halfon, M. S., Buck, M. J., & Sinha, S. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-68 · Cited by 20
“However these results are in contrast to expression analysis studies of breast cancer by other laboratories, which have suggested increased Elf5 expression in breast cancer [2,4].”
BackgroundResultThe Role of Pea3 Group Transcription Factors in Esophageal Squamous Cell Carcinoma
Yuen, H., McCrudden, C. M., Chan, K.-K., Chan, Y.-P., Wong, M. L.-Y., Chan, K. Y.-K., Khoo, U., Law, S. Y.-K., Srivastava, G., Lappin, T. R. J., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.004 · Cited by 15
Differential Sensitivity of Mouse Epithelial Tissues to the Polyomavirus Middle T Oncogene
Ceceña, G., Wen, F., Cardiff, R. D., & Oshima, R. G. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050443 · Cited by 15
“Quantitative, reverse transcriptase-dependent PCR (QPCR) was performed on a Stratagene MX3000 machine using the SYBR Green detection method as described previously.(18) Southern blots were performed as described previously.”
Self-citationJedlicka, P., Sui, X., Sussel, L., & Gutierrez‐Hartmann, A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080409 · Cited by 15
PDEF downregulates stathmin expression in prostate cancer
Zhang, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1392 · Cited by 12
“Ets proteins control many important cellular processes, including proliferation, differentiation, angiogenesis and apoptosis (4-11).”
BackgroundChen, E., Zhou, S., Pang, X., Yin, D., Miao, P.-Z., Yang, Y., Chen, Q., Zhu, K., Gao, D., Liu, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14924 · Cited by 12
Prostate-derived Ets factor, an oncogenic driver in breast cancer
Sood, A. K., Geradts, J., & Young, J. S. (2017) · Tumor Biology · doi:10.1177/1010428317691688 · Cited by 12
Characterization of human septic sera induced gene expression modulation in human myocytes.
Hussein, S., Michael, P., Brabant, D., Omri, A., Narain, R., Passi, K., Ramana, C. V., Parrillo, J. E., Kumar, A., Parissenti, A. M., et al. (2009) · PubMed · Cited by 12
Identification of endothelial genes up-regulated in vivo
Pai, J., & Ruoslahti, E. I. (2005) · Gene · doi:10.1016/j.gene.2004.12.034 · Cited by 12
Wang, H., Yan, C., Asangani, I. A., Allgayer, H., & Boyd, D. B. (2006) · Oncogene · doi:10.1038/sj.onc.1210003 · Cited by 12
“…Ets-1 and Ets-2 failed to generate a ternary Oncogene complex (Figure 8, lane 5) suggesting that these transcription factors are not recognized by the nonconsensus Ets binding motif although not eliminating the possibility of other bound Ets family members (Yang et al., 1996; Galang et al., 2004).”
BackgroundPark, S., Do, H., Ha, W. T., Han, M., Song, H., Uhm, S. J., Chung, H., & Kim, J.-H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00985 · Cited by 11
Sutter, W., Stein, E., Koehn, J., Schmidl, C., Lezaic, V., Ewers, R., & Turhani, D. (2009) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2009.01.007 · Cited by 10
“Although translational regulation is not a widely observed phenomenon in the Ets-family of transcription factors (Galang et al., 2004), it has already been reported for some other members of this family like Pse (Prostate specific Ets-factor) (Nozawa et al.”
Background
Metadata
- Authors
- Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- McGill University (CA)
- Corresponding author
- Hauser, Craig A.
- ORCID
- Muller, William J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 12
- Pages
- 11281-11292
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087260415
- Cited by
- 132
- References
- 74
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 7
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca063130-07)
- National Cancer Institute (R01CA074547, CA30199, CA74547, CA63130, P30CA030199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- ETS transcription factors, mammary tumors, mammary gland, gene expression profiling, maspin, mammary tumor progression
- MeSH terms
- Animals, Cell Line, DNA-Binding Proteins, Gene Expression Regulation, Mammary Glands, Animal, Mammary Neoplasms, Experimental, Transcription Factors, Polymerase Chain Reaction, DNA, Complementary, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.